# A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria

> **NCT00843388** · PHASE4 · UNKNOWN · sponsor: **Steno Diabetes Center Copenhagen** · enrollment: 20 (estimated)

## Conditions studied

- Diabetes Mellitus
- Nephropathy
- Blood Pressure

## Interventions

- **DRUG:** Spironolacton (hexalacton(R))
- **DRUG:** placebo tablet

## Key facts

- **NCT ID:** NCT00843388
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2009-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00843388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00843388, "A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00843388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*